NCT05028634 · Interventional trial
Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy
Overall registry status Completed
Phase 3
Conditions Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting
Delaware Valley sites
- Thomas Jefferson University - Clinical Research Institute · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory